Savagnone E, Caruso V, Mondello P, Patti S, Spicola L, Spanò C
Acta Diabetol Lat. 1980 Jul-Dec;17(3-4):207-11. doi: 10.1007/BF02581320.
The presence of HBV markers was determined in 149 serum samples obtained from diabetic patients and was compared with a normal population. Diabetics have the same incidence of HBsAg but significantly higher anti-HBc antibodies. These differences were seen in the group of diabetics on oral hypoglycemic therapy. These results cannot yet be explained.
在从糖尿病患者获取的149份血清样本中测定了乙肝病毒（HBV）标志物的存在情况，并与正常人群进行了比较。糖尿病患者的乙肝表面抗原（HBsAg）发生率相同，但抗乙肝核心抗体（anti-HBc）显著更高。在接受口服降糖治疗的糖尿病患者组中观察到了这些差异。这些结果目前尚无法解释。
